168 related articles for article (PubMed ID: 38173492)
1. Genetic variants of m7G modification genes influence neuroblastoma susceptibility.
Liu J; Deng C; Lin H; Zhang X; Zhu J; Zhou C; Wu H; He J
Heliyon; 2024 Jan; 10(1):e23658. PubMed ID: 38173492
[TBL] [Abstract][Full Text] [Related]
2.
Deng L; Hua RX; Deng C; Zhu J; Zhang Z; Cheng J; Zhang J; Zhou H; Li S; Ruan J; Liu G; He J; Fu W
J Cancer; 2023; 14(8):1293-1300. PubMed ID: 37283791
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma susceptibility and association of N7-methylguanosine modification gene polymorphisms: multi-center case-control study.
Lin H; Liao F; Liu J; Yang Z; Zhang J; Cheng J; Zhou H; Li S; Li L; Li Y; Zhuo Z; He J
Pediatr Res; 2024 Jun; ():. PubMed ID: 38871802
[TBL] [Abstract][Full Text] [Related]
4. Association of RNA m
Zhu J; Liu X; Chen W; Liao Y; Liu J; Yuan L; Ruan J; He J
Biomed Res Int; 2023; 2023():3678327. PubMed ID: 36733406
[TBL] [Abstract][Full Text] [Related]
5. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
6.
He S; Zhu J; Xiao Z; Liu J; Zhang J; Li Y; Yang Z; Cheng J; Li S; Li L; He J; Xu D
J Cancer; 2022; 13(12):3342-3347. PubMed ID: 36186903
[TBL] [Abstract][Full Text] [Related]
7. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
8. METTL1 gene polymorphisms synergistically confer hepatoblastoma susceptibility.
Ge L; Zhu J; Liu J; Li L; Zhang J; Cheng J; Li Y; Yang Z; Li S; He J; Zhang X
Discov Oncol; 2022 Aug; 13(1):77. PubMed ID: 35986847
[TBL] [Abstract][Full Text] [Related]
9. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
[TBL] [Abstract][Full Text] [Related]
10. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
11. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
Front Genet; 2022; 13():998147. PubMed ID: 36226166
[No Abstract] [Full Text] [Related]
12. METTL1 mediated tRNA m
Zhao P; Xia L; Chen D; Xu W; Guo H; Xu Y; Yan B; Wu X; Li Y; Zhang Y; Zhang X
Exp Hematol Oncol; 2024 Jan; 13(1):8. PubMed ID: 38268051
[TBL] [Abstract][Full Text] [Related]
13. Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population.
Zhou C; Wang Y; He L; Zhu J; Li J; Tang Y; Zhou H; He J; Wu H
Mol Ther Oncolytics; 2021 Mar; 20():3-11. PubMed ID: 33575466
[TBL] [Abstract][Full Text] [Related]
14. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
[TBL] [Abstract][Full Text] [Related]
15. N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancer.
Cai M; Yang C; Wang Z
Am J Cancer Res; 2023; 13(5):1640-1655. PubMed ID: 37293166
[TBL] [Abstract][Full Text] [Related]
16. Novel roles of METTL1/WDR4 in tumor via m
Cheng W; Gao A; Lin H; Zhang W
Mol Ther Oncolytics; 2022 Sep; 26():27-34. PubMed ID: 35784404
[TBL] [Abstract][Full Text] [Related]
17. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
[TBL] [Abstract][Full Text] [Related]
18. Internal m7G methylation: A novel epitranscriptomic contributor in brain development and diseases.
Xia X; Wang Y; Zheng JC
Mol Ther Nucleic Acids; 2023 Mar; 31():295-308. PubMed ID: 36726408
[TBL] [Abstract][Full Text] [Related]
19. N
Han H; Zheng S; Lin S
Autophagy; 2023 Jan; 19(1):360-362. PubMed ID: 35574843
[TBL] [Abstract][Full Text] [Related]
20.
Liu J; Cheng J; Li L; Li Y; Zhou H; Zhang J; Li S; Xia H; He J; Yang Z
J Cancer; 2021; 12(8):2465-2471. PubMed ID: 33758623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
